References
- Scully C, Bagan J. Oral squamous cell carcinoma overview. Oral Oncol 2009; 45: 301-8. doi: 10.1016/j.oraloncology.2009.01.004
- Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer, Oral Oncol 2009; 45: 309-16. doi: 10.1016/j.oraloncology.2008.06.002
- Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019; 144: 1941-53. doi: 10.1002/ijc.31937
- Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 2013; 31: 4550-9. doi: 10.1200/ JCO.2013.50.3870
- Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woolgar JA. The prognostic implications of the surgical margin in the oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2003; 32: 30-4. doi: 10.1054/ijom.2002.03135
- Scher ED, Romesser PB, Chen C, Ho F, Wuu Y, Sherman EJ, et al. Definitive chemoradiation for primary oral cavity carcinoma: a single institution experience. Oral Oncol 2015; 51: 709-15. doi: 10.1016/j.oraloncology.2015.04.007
- Foster CC, Melotek JM, Brisson RJ, Seiwert TY, Cohen EEW, Stenson KM, et al. Definitive chemoradiation for locally-advanced oral cavity cancer: a 20-year experience. Oral Oncol 2018; 80: 16-22. doi: 10.1016/j.oraloncology.2018.03.008
- Lyer N, Tan DSW, Tan VKM, Wang W, Hwang J, Tan NC,et al. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis. Cancer 2015; 121: 1599-607. doi: 10.1002/cncr.29251
- Pignon JP, le Maitre A, Maillard E, Bourhis J, Group M-NC. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92: 4-14. doi: 10.1016/j.radonc.2009.04.014
- Stenson KM, Kunnavakkam R, Cohen EE, Portugal LD, Blair E, Haraf DJ, et al. Chemoradiation for patients with advanced oral cavity cancer. Laryngoscope 2010; 120: 93-9. doi: 10.1002/lary.20716
- Studer G, Brown M, Bredell M, Graetz KW, Huber G, Linsenmeier C, et al. Follow up after IMRT in oral cavity cancer: update. Radiat Oncol 2012; 7: 84. doi: 10.1186/1748-717X-7-84
- Kessel KA, Bohn C, Engelmann U, Oetzel D, Bougatf N, Bendl R, et al. Five-year experience with setup and implementation of an integrated database system for clinical documentation and research. Comput Methods Programs Biomed 2014; 114: 206-17. 10.1016/j.cmpb.2014.02.002
- Lang K, Akbaba S, Held T, Kargus S, Horn D, Bougatf N, et al. Definitive radiotherapy vs. postoperative radiotherapy for lower gingival carcinomas of the mandible: a single-center report about outcome and toxicity. Strahlenther Onkol 2019; 195: 819-29. doi: 10.1007/s00066-019-01484-z
- Eisbruch A. Intensity-modulated radiation therapy in the treatment of head and neck cancer. Nat Clin Pract Oncol 2005; 2: 34-9. doi: 10.1038/ ncponc0058
- Huang SH, O’Sullivan B. Oral cancer: current role of radiotherapy and chemotherapy. Med Oral Patol Oral Cir Bucal 2013; 18: e233-40. doi: 10.4317/medoral.18772
- Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 2000; 355: 949-55. doi: 10.1016/S0140-6736(00)90011-4
- Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 2005; 27: 843-50. doi: 10.1002/hed.20279
- Lin CY, Wang HM, Kang CJ, Lee LY, Huang SF, Fan KH, et al. Primary tumor site as a predictor of treatment outcome for definitive radiotherapy of advanced-stage oral cavity cancers. Int J Radiat Oncol Biol Phys 2010; 78: 1011-9. doi: 10.1016/j.ijrobp.2009.09.074
- Hosni A, Chiu K, Huang SH, Xu W, Huang J, Bayley A, et al. Non-operative management for oral cavity carcinoma: definitive radiation therapy as a potential alternative treatment approach. Radiother Oncol 2020; 154: 70-5. doi: 10.1016/j.radonc.2020.08.013
- Murthy V, Agarwal JP, Laskar SG, Gupta T, Budrukkar A, Pai P, et al. Analysis of prognostic factors in 1180 patients with oral cavity primary cancer treated with definitive or adjuvant radiotherapy. J Cancer Res Ther 2010; 6: 282-9. doi: 10.4103/0973-1482.73360
- Zelefsky MJ, Harrison LB, Fass DE, Armstrong JG, Shah JP, Strong EW. Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins. Int J Radiat Oncol Biol Phys 1993; 25: 17-21. doi: 10.1016/0360-3016(93)90139-m
- Salama JK, Seiwert TY, Vokes EE. Chemoradiotherapy for locally advanced head and neck cancer. J Clin Oncol 2007; 25: 4118-26. doi: 10.1200/ JCO.2007.12.2697
- Tobias JS, Monson K, Gupta N, Macdougall H, Glaholm J, Hutchison I, et al. Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial. Lancet Oncol 2010; 11: 66-74. doi:10.1016/S1470-2045(09)70306-7
- Pederson AW, Salama JK, Witt ME, Stenson KM, Blair EA, Vokes EE, et al. Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer. Am J Clin Oncol 2011; 34: 356-61. doi: 10.1097/COC.0b013e3181e8420b
- Gebre-Medhin M, Brun E, Engstrom P, Haugen Cange H, Hammarstedt-Nordenvall L, Reizenstein J, Nyman J, et al. ARTSCAN III: a randomized Phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer. J Clin Oncol 2021; 39: 38-47. doi: 10.1200/JCO.20.02072
- Shah JP, Gil Z. Current concepts in management of oral cancer – surgery. Oral Oncol 2009; 45: 394-401. doi: 10.1016/j.oraloncology.2008.05.017
- Kerr P, Myers CL, Butler J, Alessa M, Lambert P, Cooke AL. Prospective functional outcomes in sequential population based cohorts of stage III/ IV oropharyngeal carcinoma patients treated with 3D conformal vs. intensity modulated radiotherapy. J Otolaryngol Head Neck Surg 2015; 44: 17. doi: 10.1186/s40463-015-0068-429.
- Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol 2011; 100: 33-40. doi: 10.1016/j.radonc.2011.05.036
- Reuther T, Schuster T, Mende U, Kübler A. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients – a report of a thirty year retrospective review. Int J Oral Maxillofac Surg 2003; 32: 28995. doi: 10.1054/ijom.2002.0332